Formulation and stability study of hydroxychloroquine sulfate oral suspensions

References

• Casian A, Sangle SR, D'Cruz DP. 2018. New use for an old treatment: hydroxychloroquine as a potential treatment for systemic vasculitis. Autoimmun Rev. 17(7):660–664.
   PubMed Web of Science ®Google Scholar
• EMA: Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668): European Medicines Agency; [accessed 2020 Aug 07]. https://www.ema.europa.eu/en/documents/scientific-guideline/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf.
   Google Scholar
• EMA: ICH Topic Q1A(R2): stability testing of new drug substances and products: European Medicines Agency; [accessed 2020 Aug 07]. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.pdf.
   Google Scholar
• Espinola RG, Pierangeli SS, Gharavi AE, Harris EN, Ghara AE. 2002. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost. 87(3):518–522.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia 8.0. 2013. Efficacy of antimicrobial preservation 01/2011:50103. EDQM Council of Europe 8th edition, Strasbourg, France, 600–601.
   Google Scholar
• Food Drug and Administration. FDA: Guidance for industry: drug stability guidelines; [accessed 2020 Aug 07]. https://www.fda.gov/media/69957/download.
   Google Scholar
• Food Drug and Administration. FDA: Plaquenil summary of product characteristics; [accessed 2020 Aug 07]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/009768Orig1s051lbl.pdf.
   Google Scholar
• Garra G, Singer AJ, Taira BR, Chohan J, Cardoz H, Chisena E, Thode HC. Jr. 2010. Validation of the Wong-Baker FACES Pain Rating Scale in pediatric emergency department patients. Acad Emerg Med. 17(1):50–54.
   PubMed Web of Science ®Google Scholar
• Guedes MDV, Marques MS, Guedes PC, Contri RV, Kulkamp Guerreiro IC. 2020. The use of electronic tongue and sensory panel on taste evaluation of pediatric medicines: a systematic review. Pharm Dev Technol. 10:1–19.
   Google Scholar
• Lajoinie A, Henin E, Kassai B. 2015. [Oral formulation of choice for children]. Arch Pediatr. 22(8):877–885.
   PubMed Web of Science ®Google Scholar
• Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, Flanagan T, Kendall R, Tuleu C. 2015. Formulation factors affecting acceptability of oral medicines in children. Int J Pharm. 492(1–2):341–343.
   PubMed Web of Science ®Google Scholar
• Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, Flanagan T, Tuleu C. 2014. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 74(16):1871–1889.
   PubMed Web of Science ®Google Scholar
• Luffy R, Grove SK. 2003. Examining the validity, reliability, and preference of three pediatric pain measurement tools in African-American children. Pediatr Nurs. 29(1):54–59.
   PubMedGoogle Scholar
• McHenry AR, Wempe MF, Rice PJ. 2017. Stability of extemporaneously prepared hydroxychloroquine sulfate 25-mg/ml suspensions in plastic bottles and syringes. Int J Pharm Compd. 21(3):251–254.
   PubMedGoogle Scholar
• Miranda S, Billoir P, Damian L, Thiebaut PA, Schapman D, Le Besnerais M, Jouen F, Galas L, Levesque H, Le Cam-Duchez V, et al. 2019. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: role of reduced inflammation and endothelial dysfunction. PLOS One. 14(3):e0212614
   PubMed Web of Science ®Google Scholar
• Mistry P, Batchelor H. 2017. Methodology used to assess acceptability of oral pediatric medicines: a systematic literature search and narrative review. Paediatr Drugs. 19(3):223–233.
   PubMed Web of Science ®Google Scholar
• Morrisette T, Lodise TP, Scheetz MH, Goswami S, Pogue JM, Rybak MJ. 2020. The pharmacokinetic and pharmacodynamic properties of hydroxychloroquine and dose selection for COVID-19: putting the cart before the horse. Infect Dis Ther. 9(3):561–572.
   PubMed Web of Science ®Google Scholar
• Pauli E, Joshi H, Vasavada A, Brackett J, Towa L. 2020. Evaluation of an immediate-release formulation of hydroxychloroquine sulfate with an interwoven pediatric taste-masking system. J Pharm Sci. 109(4):1493–1497.
   PubMed Web of Science ®Google Scholar
• Rand JH, Wu X-X, Quinn AS, Ashton AW, Chen PP, Hathcock JJ, Andree HAM, Taatjes DJ. 2010. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood. 115(11):2292–2299.
   PubMed Web of Science ®Google Scholar
• Roberts R, Rodriguez W, Murphy D, Crescenzi T. 2003. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 290(7):905–911.
   PubMed Web of Science ®Google Scholar
• Salunke S, Hempenstall J, Kendall R, Roger B, Mroz C, Nunn T, Tuleu C. 2011. European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary – formulating better medicines for children. Int J Pharm. 419(1–2):235–239.
   PubMed Web of Science ®Google Scholar
• Schreiber K, Breen K, Parmar K, Rand JH, Wu XX, Hunt BJ. 2018. The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Rheumatology. 57(1):120–124.
   PubMed Web of Science ®Google Scholar
• Shukla AM, Wagle Shukla A. 2019. Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues. DIC. 8:1–12.
   Google Scholar
• Ternik R, Liu F, Bartlett JA, Khong YM, Thiam Tan DC, Dixit T, Wang S, Galella EA, Gao Z, Klein S. 2018. Assessment of swallowability and palatability of oral dosage forms in children: report from an M-CERSI pediatric formulation workshop. Int J Pharm. 536(2):570–581.
   PubMed Web of Science ®Google Scholar
• Torigoe M, Sakata K, Ishii A, Iwata S, Nakayamada S, Tanaka Y. 2018. Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clin Immunol. 195:1–7.
   PubMed Web of Science ®Google Scholar
• Wagner JA, Pabon G, Terrill D, Abdel-Rahman SM. 2020. Examining a new scale for evaluating taste in children (TASTY). J Pediatr Pharmacol Ther. 25(2):131–138.
   PubMedGoogle Scholar